tiprankstipranks

Matthew Gall Insider Profile

4 Followers
Matthew Gall, CFO at iTeos Therapeutics, holds 60.43K shares in iTeos Therapeutics (Ticker: ITOS).
tipranks
Matthew Gall

Matthew Gall
iTeos Therapeutics (ITOS)
CFO

Ranked #7,752 out of 98,624 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+62.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$649K
100.00%
A breakdown of Matthew Gall's holdings

Insider Roles

iTeos Therapeutics
(ITOS)
CFO
Roles that Matthew Gall holds in companies

Most Profitable Insider Trade

Stock:
iTeos Therapeutics
(ITOS)
Rating:Informative Buy
Date:Jun 16, 2021 - Jun 16, 2022
Return:+83.80%
The most profitable trade made by Matthew Gall

Matthew Gall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
iTeos Therapeutics
Dec 07, 2023
CFO
Uninformative Buy
$649.01K
Success Rate for
ITOS
4 out of 4 profitable transactions on
ITOS
100%
Average Return for
ITOS
Average return per transaction on
ITOS
+62.35%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 16, 2021
Informative Buy
$130.40K
-
$26.08
+83.80%
Oct 12, 2021
Informative Buy
$88.88K
-
$6.16
+79.40%
Oct 12, 2023
Informative Buy
$41.85K
-
$8.37
+25.90%
Dec 07, 2023
Uninformative Buy
$0.00
-
$0.00
Dec 28, 2021
Informative Sell
$232.25K
-
$46.45
+60.30%
List of latest transactions for each holding click on a transaction to see Matthew Gall's performance on stock

Matthew Gall insider profile FAQ

What is the percentage of profitable transactions made by Matthew Gall?
The percentage of profitable transactions made by Matthew Gall is 100%.
    What is the average return per transaction made by Matthew Gall?
    The average return per transaction made by Matthew Gall is 62.30%.
      What stocks does Matthew Gall hold?
      Matthew Gall holds: ITOS stocks.
        What was Matthew Gall’s latest transaction?
        Matthew Gall latest transaction was an Uninformative Buy of ―.
          What was Matthew Gall's most profitable transaction?
          Matthew Gall’s most profitable transaction was an Informative Buy of ITOS stock on June 16, 2021. The return on the trade was 83.80%.
            What is Matthew Gall's role in iTeos Therapeutics?
            Matthew Gall's role in iTeos Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.